South Korean singer Boa
South Korean singer Boa Overseas, Dec. 18 according to Yonhap reported that South Korean legal sources revealed on the 17th, singer BoA suspicion of violating regulations of imported drugs, such as zolpidem send dependence psychotropic substances under investigation from prosecution overseas.
On the same day, SM Entertainment, a subsidiary of Baoer, responded, saying that this was a mistake caused by the ignorance of the company’s employees, and it was not a smuggling of drugs.
Singer Boa investigated
Singer Boa investigated December 16th, the Serious Cases Department of the Central District Prosecutor’s Office in Seoul, South Korea, as a suspect, summoned Boa to investigate the matter.
It is reported that Boa was discovered in the process of trying to bring the Japanese prescription drug Zolpidem into South Korea in the name of domestic employees through employees of the Japanese branch of the brokerage company SM Entertainment.
Boa smuggling of drugs from Japan
Boa smuggling of drugs from Japan SM Entertainment issued a position statement that day, stating that this was a mistake caused by the ignorance of the company’s employees, and it was not a smuggled drug entry.
The employee prescribes drugs at a local regular hospital, but does not realize that prescription drugs normally prescribed overseas may also be regulated in South Korea.
The brokerage company said that Boa recently followed the doctor’s order to take prescription sleeping pills but the side effects were relatively large, so they sent the sleep aids she took during the Japanese event through the company’s overseas employees.
However, the employee made a hasty decision according to the notice from the local post office that “the drug ingredient list can be sent overseas” and made a mistake.
The company also promised that the employee will actively cooperate with the prosecutor’s investigation.
